Related Experiment Video
Updated: Jun 28, 2025

A Zebrafish Embryo Model for In Vivo Visualization and Intravital Analysis of Biomaterial-associated Staphylococcus aureus Infection
Published on: January 7, 2019
Infectious Diseases Impact on Biomedical Devices and Materials.
Matthew M Brigmon1, Robin L Brigmon2
1Department of Infectious Diseases and Pulmonary Critical Care, Long School of Medicine, UT Health San Antonio, San Antonio, USA.
Biomedical device infections are a growing problem due to antibiotic resistance. This study reviews challenges, pathogenesis, and novel nanostructured materials for preventing and treating these infections.
Area of Science:
- Biomaterials Science
- Infectious Diseases
- Nanotechnology
Background:
- Infectious diseases and nosocomial infections pose significant challenges in healthcare, particularly concerning biomedical materials and devices.
- Current polymer materials often fail to resist microbial growth, exacerbating issues with biomedical implants.
- Increasing microbial antibiotic resistance complicates the management of infections associated with medical devices.
Purpose of the Study:
- To review the challenges in diagnosing device-related infections and their contribution to antibiotic resistance.
- To conceptualize the pathogenesis of device-related infections, focusing on biofilm formation and host immune responses.
- To explore current and future preventative strategies, treatment options, and the development of antimicrobial nanostructured materials for implantable devices.
Main Methods:
- Literature review of device-related infection pathogenesis, diagnosis, and treatment.
- Conceptualization of biofilm formation and host immune/antimicrobial therapy interactions.
- Analysis of current and developing preventative strategies and novel treatment approaches.
- Review of potential manufacturing methods for nanostructured antimicrobial materials.
Main Results:
- Difficulty in diagnosing device-related infections contributes to increased microbial antibiotic resistance.
- Biofilm formation is a critical factor in device-related infections, involving host immune and antimicrobial therapies.
- Current and emerging strategies aim to prevent infectious diseases associated with biomedical devices.
- Development of nanostructured materials with antimicrobial functionality for implantable devices is a promising area.
Conclusions:
- There is a critical need for improved treatment strategies to combat rising antimicrobial resistance.
- Novel nanostructured materials offer potential for enhanced antimicrobial functionality in implantable devices.
- Integrated approaches combining prevention and novel treatments are essential for improving care with biomedical devices.
Related Concept Videos
Bacterial Signaling
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

